CY1110644T1 - 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις - Google Patents

5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις

Info

Publication number
CY1110644T1
CY1110644T1 CY20101100473T CY101100473T CY1110644T1 CY 1110644 T1 CY1110644 T1 CY 1110644T1 CY 20101100473 T CY20101100473 T CY 20101100473T CY 101100473 T CY101100473 T CY 101100473T CY 1110644 T1 CY1110644 T1 CY 1110644T1
Authority
CY
Cyprus
Prior art keywords
hypercapillary
analogues
treatment
diseases
trihydroxyheptanoic acid
Prior art date
Application number
CY20101100473T
Other languages
English (en)
Inventor
Peter G Klimko
Mark R Hellberg
David P Bingaman
Daniel A Gamache
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of CY1110644T1 publication Critical patent/CY1110644T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Αναφέρονται συνθέσεις που περιέχουν 5,6,7-τριυδροξυεπτανοϊκό οξύ και τα ανάλογά του και οι χρήσεις τους για την θεραπεία παθήσεων του οπίσθιου τμήματος του οφθαλμού όπως και παθήσεων που χαρακτηρίζονται από κυτταρικό υπέρ πολλαπλασιασμό ή αγγειογέννηση.
CY20101100473T 2004-11-09 2010-05-28 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις CY1110644T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62620904P 2004-11-09 2004-11-09
EP05824279A EP1809270B1 (en) 2004-11-09 2005-11-08 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Publications (1)

Publication Number Publication Date
CY1110644T1 true CY1110644T1 (el) 2015-04-29

Family

ID=35809550

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100473T CY1110644T1 (el) 2004-11-09 2010-05-28 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις

Country Status (20)

Country Link
US (2) US7879905B2 (el)
EP (1) EP1809270B1 (el)
JP (3) JP2008519763A (el)
KR (1) KR101237534B1 (el)
CN (1) CN101052387A (el)
AT (1) ATE461696T1 (el)
AU (1) AU2005304733B2 (el)
BR (1) BRPI0517972A (el)
CA (1) CA2584286C (el)
CY (1) CY1110644T1 (el)
DE (1) DE602005020178D1 (el)
DK (1) DK1809270T3 (el)
ES (1) ES2340786T3 (el)
HK (1) HK1110768A1 (el)
MX (1) MX2007004622A (el)
PL (1) PL1809270T3 (el)
PT (1) PT1809270E (el)
SI (1) SI1809270T1 (el)
WO (1) WO2006052950A1 (el)
ZA (1) ZA200703992B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879905B2 (en) * 2004-11-09 2011-02-01 Alcon, Inc. 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
US20060154981A1 (en) * 2005-01-12 2006-07-13 Alcon, Inc. Method of reducing intraocular pressure and treating glaucoma
US7687539B1 (en) 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
EP2079459A2 (en) * 2006-11-07 2009-07-22 Alcon Research, Ltd. Method of treating asthma, allergic rhinitis, and skin disorders
EA201290442A1 (ru) * 2009-12-04 2012-11-30 Юклид Системз Корпорэйшн Композиция и способы профилактики и лечения макулярной дегенерации, диабетической ретинопатии и диабетического макулярного отека
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
JP2013521230A (ja) * 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975537A (en) 1985-10-23 1990-12-04 The Upjohn Company Δ9(11) -angiostatic steroids
US4771042A (en) 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
JP2834512B2 (ja) * 1990-01-30 1998-12-09 帝人株式会社 リポキシン誘導体を有効成分とする疾患治療剤
US5441951A (en) 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US6048897A (en) * 1993-06-15 2000-04-11 Brigham And Women's Hospital Lipoxin compounds and their use in treating cell proliferative disorders
JPH08268886A (ja) 1995-03-31 1996-10-15 Eisai Co Ltd 血管新生抑制剤
US6645978B1 (en) * 1999-11-09 2003-11-11 Alcon, Inc. Lipoxin A4 and its analogs for the treatment of dry eye
AR030345A1 (es) 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
PT1406698E (pt) 2001-03-02 2009-01-12 Brigham & Womens Hospital Análogos de lipoxina como novos inibidores da angiogénese
MXPA06013170A (es) * 2004-05-14 2007-02-13 Alcon Inc Metodo para tratar trastornos de queratoconjuntivitis seca y uveitis.
US7879905B2 (en) * 2004-11-09 2011-02-01 Alcon, Inc. 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Also Published As

Publication number Publication date
MX2007004622A (es) 2007-06-11
US20060099248A1 (en) 2006-05-11
AU2005304733A1 (en) 2006-05-18
KR101237534B1 (ko) 2013-03-04
US7879905B2 (en) 2011-02-01
CA2584286C (en) 2014-01-14
HK1110768A1 (en) 2008-07-25
ATE461696T1 (de) 2010-04-15
US20110082200A1 (en) 2011-04-07
BRPI0517972A (pt) 2008-10-21
AU2005304733B2 (en) 2011-04-07
WO2006052950A1 (en) 2006-05-18
ES2340786T3 (es) 2010-06-09
ZA200703992B (en) 2009-08-26
CA2584286A1 (en) 2006-05-18
PL1809270T3 (pl) 2010-08-31
SI1809270T1 (sl) 2010-07-30
DE602005020178D1 (de) 2010-05-06
KR20070083980A (ko) 2007-08-24
PT1809270E (pt) 2010-05-25
JP2008519763A (ja) 2008-06-12
JP2012107073A (ja) 2012-06-07
DK1809270T3 (da) 2010-06-14
EP1809270B1 (en) 2010-03-24
EP1809270A1 (en) 2007-07-25
JP2014198730A (ja) 2014-10-23
CN101052387A (zh) 2007-10-10

Similar Documents

Publication Publication Date Title
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
CY1117576T1 (el) Δινουκλεοτιδικα προφαρμακα
ATE381535T1 (de) Phenethanolaminderivate
CY1107074T1 (el) Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
ATE384058T1 (de) Thiazolderivate
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
EE200300324A (et) Asendatud alküülamiini derivaadid ja nende kasutamismeetodid
DE60026155D1 (de) Einige alkylendiamin-substituierte heterocyclen
SE0102299D0 (sv) Compounds
ATE489379T1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
SE0102300D0 (sv) Compounds
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
ATE524181T1 (de) Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
DK0939627T3 (da) Pentaflourbenzensulfonamider og analoger
ATE448785T1 (de) Behandlung von entzündlicher darmerkrankung
SE0002739D0 (sv) New use
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
DE602004009166D1 (de) Neue Analoga von Nitrobenzylthioinosin
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV